Haploinsufficiency of RNPS1, a component of the exon junction complex, causes a syndromic neurodevelopmental disorder with skeletal anomalies
ASHG 2026
Daniel G. Calame, Shruti Pande, Andre Mueller, Nikhita Gogate, Moez Dawood, Mira Gandhi, Davut Pehlivan, Lore Vallaeys, Koen Devriendt, Rami Abou Jamra, Eva-Maria Kraus, Almuth Caliebe, Thomas Neumann, Kristen Mehner, Viktoria Bothe, Raymond J Louie, Elliot Stolerman, Gaber Bergant, Urška Kotnik, Karin Writzl, Karen Niederhoffer, Sonja Strang-Karlsson, Louise C. Wilson, Alistair Pagnamenta, Gabriela Jones, Guillaume Jouret, Dominik Brado, Lucas Hérissant, Isabella Herman, Valeria Naranjo, Ivy Johnson, Lidia Pezzani, Maria Iascone, Brooklynn Gasser, Lillian Garrett, Lore Becker, Nadine Spielmann, Claudia Seisenberger, Susan Marschall, Patricia da Silva-Buttkus, Sabine M Hölter, Helmut Fuchs, Valérie Gailus-Durner, Martin Hrabe de Angelis, V. Reid Sutton, Jennifer E. Posey, Richard A. Gibbs, Niels Gehring, James R. Lupski, Chaya N. Murali
Background
RNPS1 encodes RNA Binding Protein with Serine-Rich Domain 1, a peripheral component of the exon junction complex (EJC). The EJC assembles near exon-exon junctions and interacts with the spliceosome to regulate splicing and nonsense-mediated decay. While core EJC genes RBM8A and EIF4A3 are linked to Mendelian traits, RNPS1 has not been associated with disease. Here, we characterize the phenotypic consequences of RNPS1 haploinsufficiency in humans and mice and the molecular consequence of pathogenic RNPS1 missense variants.
Methods
Individuals with de novo RNPS1 missense or loss-of-function (LOF) variants were identified through family-based genomics. Rescue experiments were performed in HEK293 cells depleted of endogenous RNPS1. The phenotypic features of Rnps1+/- mice were characterized.
Results
We identified 23 individuals with de novo RNPS1 variants, including 4 missense, 4 nonsense, 3 frameshifts, and 5 splice-site variants in addition to 4 non-recurrent deletions (range 114.5-372.6 kb) encompassing RNPS1. A recurrent nonsense variant, c.187C>T p.R63X, was seen in 4 individuals. Phenotypic features included developmental delay (20/23), facial dysmorphology (19/23), skeletal malformations (23/23) including vertebral segmentation defects and hand and foot patterning defects, and congenital heart disease (11/23). Brain imaging was either normal (2/14) or demonstrated reduced white matter volume and corpus callosum thinning (12/14). Human Phenotype Ontology analysis shows RNPS1 cases exhibit significant phenotypic overlap with spliceosomopathies while forming a distinctive syndrome cluster. RNPS1 missense variants I165N and H176P exhibit reduced expression and abnormal nuclear aggregation, while G226E is stable but disrupts EJC binding. I165N, H176P, and G226E fail to rescue splicing defects caused by endogenous RNPS1 depletion. Mini-gene assays demonstrate RNPS1 splice site variants and the missense variant c.818G>C p.R273T disrupt normal mRNA splicing. Rnps1+/- mice exhibit neurobehavioral deficits including decreased locomotor activity and speed in open field testing, reduced grip strength, and abnormal cardiac physiology.
Conclusion
Our findings establish RNPS1 haploinsufficiency as a cause of a distinctive neurodevelopmental-skeletal syndrome, linking spliceosome and EJC dysfunction to brain and skeletal development. The skeletal findings demonstrate a previously unappreciated role for RNPS1 in somitogenesis and limb bud development.
Related publications